The results of in vivo experiment indicated that PTX treatment alone could not inhibit tumor growth, but rAd-p53 + PTX significantly inhibited tumor growth in PTC, which indicated that p53 activation was necessary for the antitumor activity of PTX in PTC. The gene discussed is TP53; the disease is neoplasm.